You are here
Generic Depo-Provera Granted Final Approval by FDA
Medroxyprogesterone Acetate Injectable Suspension is the generic equivalent of Pfizer's Depo-Provera®, an injectable contraceptive.
Annual sales of the brand product sold in syringes are approximately $109 million.
This is the second presentation of this product for which Teva has obtained a generic drug approval. In July, the FDA granted final approval for Teva's ANDA for Medroxyprogesterone Acetate Injectable Suspension USP, 150 mg/mL in single-dose vials. Shipment of this product commenced in September.
Source: Teva Pharmaceutical Industries